IL28B Genotype Does Not Correlate with HIV Control in African Americans

Clinical and Translational Science

Volumn 4, Issue 4, 2011, Pages 282-284

  Sajadi, Mohammad M ^a   Shakeri, Nahzinine ^a   Talwani, Rohit ^a   Howell, Charles D ^a   Pakyz, Ruth ^a   Redfield, Robert R ^a   Parsa, Afshin ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Elite controller; HCV; HIV; IL28B; Natural viral suppressor

Indexed keywords

INTERLEUKIN 28B;

ADULT; AFRICAN AMERICAN; AGED; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION CONTROL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SUPPRESSOR GENE; VIRAL CLEARANCE; VIRUS LOAD; VIRUS REPLICATION; WESTERN BLOTTING;

ADULT; AFRICAN AMERICANS; AGED; ALLELES; COHORT STUDIES; DEMOGRAPHY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HIV INFECTIONS; HUMANS; INTERLEUKINS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; YOUNG ADULT;

HEPATITIS C VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 80052232595     PISSN: 17528054     EISSN: 17528062     Source Type: Journal    
DOI: 10.1111/j.1752-8062.2011.00307.x     Document Type: Article

References (10)

1. Thomas DL, Thio CL, Martin MP, Qi Y, Ge D, O'Huigin C, Kidd J, Kidd K, Khakoo SI, Alexander G, et al. Genetic variation in IL28B and spontaneous clearance of hepatitis C virus. Nature. 2009; 461(7265): 798-801.
2. Ge D, Fellay J, Thompson AJ, Simon JS, Shianna KV, Urban TJ, Heinzen EL, Qiu P, Bertelsen AH, Muir AJ, et al. Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature. 2009; 461(7262): 399-401. Epub 2009 Aug 16.
3. Rallón NI, Naggie S, Benito JM, Medrano J, Restrepo C, Goldstein D, Shianna KV, Vispo E, Thompson A, McHutchison J, et al. Association of a single nucleotide polymorphism near the interleukin-28B gene with response to hepatitis C therapy in HIV/hepatitis C virus-coinfected patients. AIDS. 2010; 24(8): F23-F29.
4. Sheppard P, Kindsvogel W, Xu W, Henderson K, Schlutsmeyer S, Whitmore TE, Kuestner R, Garrigues U, Birks C, Roraback J, et al. IL-28, IL-29 and their class II cytokine receptor IL-28R. Nat Immunol. 2003; 4(1): 63-68.
5. Ma D, Jiang D, Qing M, Weidner JM, Qu X, Guo H, Chang J, Gu B, Shi PY, Block TM, et al. Antiviral effect of interferon lambda against West Nile virus. Antiviral Res. 2009; 83(1): 53-60.
6. Sajadi MM, Heredia A, Le N, Constantine N, Redfield RR. HIV-1 natural viral suppressors: control of viral replication in the absence of therapy. AIDS. 2007; 21(4): 517-519.
7. Sajadi MM, Shakeri N, Talwani R, Redfield RR. Hepatitis C infection in HIV-1 natural viral suppressors. AIDS. 2010; 24(11): 1689-1695.
8. Conjeevaram HS, Fried MW, Jeffers LJ, Terrault NA, Wiley-Lucas TE, Afdhal N, Brown RS, Belle SH, Hoofnagle JH, Kleiner DE, et al.; Virahep-C Study Group. Peginterferon and ribavirin treatmentin African American and Caucasian American patients with chronic Hepatitis CGenotype 1. Gastroenterology. 2006; 31(2): 470-477.
9. Salgado M, Kirk GD, Cox A, Rutebemberwa A, Higgins Y, Astemborski J, Thomas DL, Thio CL, Sulkowski MS, Blankson JN. Protective interleukin-28B genotype affects hepatitis C virus clearance, but does not contribute to HIV-1 control in a cohort of African-American elite controllers/suppressors. AIDS. 2010, Nov 19. [Epub ahead of print]
10. Martin MP, Qi Y, Goedert JJ, Hussain SK, Kirk GD, Hoots WK, Buchbinder S, Carrington M, Thio CL. IL28B polymorphism does not determine outcomes of hepatitis B virus or HIV infection. J Infect Dis. 2010; 202(11): 1749-1753.